These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Experimental and clinical effects of anticoagulants on cancer progression. Van Noorden CJ; van Sluis GL; Spek CA Thromb Res; 2010 Apr; 125 Suppl 2():S77-9. PubMed ID: 20434011 [No Abstract] [Full Text] [Related]
3. The roles of anticoagulants in patients with cancer. Lee AY Thromb Res; 2010 Apr; 125 Suppl 2():S8-11. PubMed ID: 20434012 [No Abstract] [Full Text] [Related]
4. Heparin in tumor progression and metastatic dissemination. Falanga A; Marchetti M Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796 [TBL] [Abstract][Full Text] [Related]
5. Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants. Wood S J Med; 1974; 5(1):7-22. PubMed ID: 4134042 [No Abstract] [Full Text] [Related]
6. [The use of anticoagulants in the chemotherapy of cancer]. Grekh IF; Shats VIa Vopr Onkol; 1969; 15(1):111-6. PubMed ID: 4891306 [No Abstract] [Full Text] [Related]
8. Antitumor and antimetastatic effect of warfarin and heparins. Bobek V; Kovarík J Biomed Pharmacother; 2004 May; 58(4):213-9. PubMed ID: 15183845 [TBL] [Abstract][Full Text] [Related]
9. Practices and pitfalls of mouse cancer models in drug discovery. Kung AL Adv Cancer Res; 2007; 96():191-212. PubMed ID: 17161681 [TBL] [Abstract][Full Text] [Related]
10. The use of heparin for treating human malignancies. Ornstein DL; Zacharski LR Haemostasis; 1999 Dec; 29 Suppl S1():48-60. PubMed ID: 10629404 [TBL] [Abstract][Full Text] [Related]
11. Clinical studies with anticoagulants to improve survival in cancer patients. Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993 [TBL] [Abstract][Full Text] [Related]
12. [Initial trials give hope. Anticoagulants against cancer?]. Hiller E MMW Fortschr Med; 2003 Apr; 145(14):16. PubMed ID: 15072270 [No Abstract] [Full Text] [Related]
13. [Therapeutic prospects of angiogenesis inhibitors in cancerology]. Bout JC; Soncin F; Vandenbunder B Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161 [No Abstract] [Full Text] [Related]
14. Low molecular weight heparins could be important in cancer. Siragusa S BMJ; 1999 Sep; 319(7213):851. PubMed ID: 10496841 [No Abstract] [Full Text] [Related]
15. Are heparins anti-neoplastic agents? Douketis JD; Lloyd NS Pol Arch Med Wewn; 2007; 117(11-12):491-3. PubMed ID: 18363247 [No Abstract] [Full Text] [Related]
16. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Niers TM; Klerk CP; DiNisio M; Van Noorden CJ; Büller HR; Reitsma PH; Richel DJ Crit Rev Oncol Hematol; 2007 Mar; 61(3):195-207. PubMed ID: 17074500 [TBL] [Abstract][Full Text] [Related]
17. Non-anti-coagulant heparins: a promising approach for prevention of tumor metastasis (review). Kragh M; Loechel F Int J Oncol; 2005 Oct; 27(4):1159-67. PubMed ID: 16142335 [TBL] [Abstract][Full Text] [Related]
18. [Autochtonous animal tumors as test models for cancer chemotherapy]. Schmähl D Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Jun; 40(6):173-5. PubMed ID: 5468737 [No Abstract] [Full Text] [Related]
19. [Do anticoagulants improve survival in patients with cancer?]. Meyer G Pathol Biol (Paris); 2008 Jun; 56(4):233-8. PubMed ID: 18456421 [TBL] [Abstract][Full Text] [Related]
20. Heparin and survival in cancer patients. van Doormaal FF; Büller HR Hematol Oncol Clin North Am; 2010 Aug; 24(4):777-84, ix-x. PubMed ID: 20659660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]